Phase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy

To compare the acute tolerance of highly conformal hypofractionated versus conventional radiotherapy.

Trial Details

NCT ID
NCT06080503
Phase
NA
Sponsor
University of Texas Southwestern Medical Center
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • LT-SABR
  • IMRT
Locations (sample)
  • Dallas, Texas, United States|32.78306,-96.80667

Key Eligibility Criteria

  • Pathologically-proven diagnosis of squamous cell carcinoma in situ, squamous cell carcinoma, or squamous cell variants (sarcomatoid, verrucous, bas…
  • Clinical stage 0-II (AJCC, 8th edition) with direct laryngoscopy showing no evidence of greater than stage II true glottic larynx cancer and PET/CT…
  • Minimum age is 18 years.
  • ECOG Performance Status 0-2

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →